Loading...

Regenicin, Inc.

RGINPNK
Healthcare
Biotechnology
$0.00
$0.00(0.00%)

Regenicin, Inc. (RGIN) Company Profile & Overview

Explore Regenicin, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Regenicin, Inc. (RGIN) Company Profile & Overview

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

SectorHealthcare
IndustryBiotechnology
CEORandall E. McCoy

Contact Information

973 557 8914
10 High Court, Little Falls, NJ, 07424

Company Facts

3 Employees
IPO DateNov 16, 2009
CountryUS
Actively Trading

Frequently Asked Questions

;